|About Us||Patients, Families & Visitors||For Health Professionals||Careers||Research & Training||Ways to Give|
Jonathan I. Izawa, MD, FRCSC
Program Director, SUO Fellowship
Departments of Surgery, Oncology & Pathology
Divisions of Urology & Surgical Oncology
Schulich School of Medicine & Dentistry
London Health Sciences Centre-Victoria Hospital
800 Commissioners Road East, Room E2-649
London, Ontario, Canada N6A 5W9
I was born and grew up in London and it was always my goal to return and treat patients in this region. I have always been interested in surgical oncology, as this subspecialty plays a crucial role in the multidisciplinary approach in caring for our cancer patients. I think a key to continuing the improvements in patient outcomes will be to focus on translational research and link the basic science researchers with surgeons/clinicians that have an interest for novel therapies and approaches to treatment for cancer patients.
Dr. Jonathan Izawa graduated from the University of Western Ontario Faculty of Medicine in 1994 and subsequently completed his Urology Residency at the University of Western Ontario. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 1999. He completed a basic science research and clinical fellowship as a McLaughlin Fellow in Urologic Oncology at the University of Texas M.D. Anderson Cancer Center in 2001.
Dr. Izawa is an Associate Professor of Surgery, Oncology and Pathology at Western University. His clinical practice primarily involves the management of urologic malignancies. He was the Program Director for the Urology Residency Program at UWO from 2005 to 2009. He is currently the Program Director for the Society of Urologic Oncology Fellowship at Western University He sits on an Editorial Board and serves as a reviewer for 14 urology journals. He has published over 100 peer-reviewed articles and 7 book chapters. He has been the principle investigator or collaborator in receiving over $1,000,000 in research grants in bladder, prostate and kidney cancer. Dr. Izawa is an Associate Scientist at the Lawson Health Research Institute and an executive member of the Canadian Urologic Oncology Group and Bladder Cancer Canada.